Main pathway: VEGFR2 and angiogenesis The best-characterized pharmacological cascade of BPC-157 involves the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) receptor
Disclosures: Arunkumar Krishnan: Nothing to Disclose, Diptasree Mukherjee: Nothing to Disclose, Carolin Schneider: Nothing to Disclose, Tinsay Woreta: Nothing to Disclose, Saleh Alqahtani: Nothing to Disclose 1161 NOTCH SIGNALING DISRUPTION AND CELLULAR CROSSTALK: DISSECTING THE PATHOPHYSIOLOGY OF BILE DUCT PAUCITY IN ALAGILLE SYNDROME USING HUMAN LIVER ORGANOIDS Marie-Agns M'CALLUM 1 Quang Toan PHAM 1 Kristen Vieira-Lomasney 1 Eytan Haddad 1 Silvia Selleri 1 Massimiliano Paganelli 1 , 1 Liver Tissue Engineering and Cell Therapy Laboratory, CHU Sainte-Justine, Universit de Montral Background: Alagille syndrome (ALGS) is a multisystemic genetic disorder resulting in severe liver disease characterized by intrahepatic bile duct paucity
.,MartinsMTS,CondessaSS,CardosoAJDS,de OliveiraJM,RochaJGP,GomesJRZuanonJASVitamin C combined with oregano essential oil, Origanum vulgare, reduced oxidative damage in Astyanax aff
De plus, il soutient la sant des vaisseaux sanguins en favorisant leur dilatation, rduisant ainsi la pression artrielle et amliorant la circulation sanguine
Cellular & Antioxidant Support